We are live on
!
Find out more
ICM
ISZO Capital Management Portfolio holdings
AUM
$2M
1-Year Est. Return
35.61%
This Fund
S&P 500
This Quarter
Est. Return
+12.69%
1 Year Est. Return
+35.61%
3 Year Est. Return
+68.24%
5 Year Est. Return
+471.73%
10 Year Est. Return
–
AUM
$64M
AUM Growth
+$2.84M
(+4.6%)
Cap. Flow
-$3.43M
Cap. Flow
% of AUM
-5.36%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
2
Reduced
–
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
+$6.32M |
| 2 |
NTP
Nam Tai Property Inc.
NTP
|
+$616K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CareDx
CDNA
|
+$10.3M |
| 2 |
ICON
Iconix Brand Group, Inc.
ICON
|
+$30K |
| 3 |
FRAN
Francesca's Holdings Corporation
FRAN
|
+$26K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 58.18% |
| 2 | Healthcare | 41.82% |
| 3 | Consumer Discretionary | 0% |
Similar funds
LBC
TA
SCM
LCMP
GIP
STC
GC
DU
ISZO Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, ISZO Capital Management held 5 positions worth $64M, up 4.6% from $61.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
ISZO Capital Management withdrew a net $3.43M in Q2 2019, closing 3 positions. Its most notable exit was CareDx, an estimated $10.3M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 60% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, ISZO Capital Management added an estimated $6.32M to Avid Bioservices, Inc. Common Stock.
- ISZO Capital Management added most to Avid Bioservices, Inc. Common Stock in Q2 2019, an estimated $6.32M increase.
- ISZO Capital Management fully exited CareDx in Q2 2019, selling an estimated $10.3M.
- ISZO Capital Management's ten largest holdings make up 100% of its $64M portfolio in Q2 2019.
- ISZO Capital Management opened 0 new positions and closed 3 in Q2 2019.
- ISZO Capital Management's portfolio value rose 4.6% quarter-over-quarter to $64M.
Based on ISZO Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.